Skip to main content
. Author manuscript; available in PMC: 2012 Jun 15.
Published in final edited form as: Nat Rev Drug Discov. 2011 Jul 29;10(9):685–697. doi: 10.1038/nrd3502

Figure 2. Structures of allosteric GABAA receptor modulators.

Figure 2

A. Preclinical and clinically tested, binding or functionally subtype-selective positive allosteric modulators (agonists). B. Preclinical and clinically tested, binding or functionally subtype-selective negative allosteric modulators (inverse agonists).